| Dr Victoria Kogan, MD | |
|
5409 Avenue O, Fort Madison, IA 52627-9601 | |
| (319) 376-2134 | |
| (319) 376-2188 |
| Full Name | Dr Victoria Kogan |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 5409 Avenue O, Fort Madison, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730412412 | NPI | - | NPPES |
| 1730412412 | Medicaid | IA | |
| 511790005 | Other | IA | WELLMARK/ BLUE CROSS/ BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 254723 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Steward Rockledge Hospital | Rockledge, FL | Hospital |
| Regional West Medical Center | Scottsbluff, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rockledge Physician Services, Llc | 1254621048 | 25 |
| Regional West Physicians Clinic | 2062301609 | 114 |
News Archive
Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad' cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU's mutual recognition procedure.
The well-educated are significantly more open to the idea of "designing" babies than the poorly educated, according to a new study by psychologists at the University of East Anglia.
Scientists at the University of Liverpool argue that anti-obesity drugs fail to provide lasting benefits for health and wellbeing because they tackle the biological consequences of obesity, and not the important psychological causes of overconsumption and weight gain.
A team of researchers will use state-of-the-art brain imaging to unlock the secrets of a genetic disease, mucopolysaccharidosis, in a landmark study the team hope will lead to new treatments for this devastating disease.
In a letter released today by the White House today to Sen. Edward Kennedy, chairman of the Senate Committee on Health, Education, Labor and Pensions, and Sen. Max Baucus, chairman of the Senate Finance Committee, President Obama "suggests he may be open to a requirement that every American have health insurance, even though he opposed the so-called individual mandate in the presidential campaign," the Washington Post reports.
› Verified 3 days ago
| Entity Name | Rockledge Physician Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538523295 PECOS PAC ID: 1254621048 Enrollment ID: O20160607001833 |
News Archive
Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad' cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU's mutual recognition procedure.
The well-educated are significantly more open to the idea of "designing" babies than the poorly educated, according to a new study by psychologists at the University of East Anglia.
Scientists at the University of Liverpool argue that anti-obesity drugs fail to provide lasting benefits for health and wellbeing because they tackle the biological consequences of obesity, and not the important psychological causes of overconsumption and weight gain.
A team of researchers will use state-of-the-art brain imaging to unlock the secrets of a genetic disease, mucopolysaccharidosis, in a landmark study the team hope will lead to new treatments for this devastating disease.
In a letter released today by the White House today to Sen. Edward Kennedy, chairman of the Senate Committee on Health, Education, Labor and Pensions, and Sen. Max Baucus, chairman of the Senate Finance Committee, President Obama "suggests he may be open to a requirement that every American have health insurance, even though he opposed the so-called individual mandate in the presidential campaign," the Washington Post reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victoria Kogan, MD 5409 Avenue O, Po Box 1470, Fort Madison, IA 52627-9601 Ph: (319) 376-2134 | Dr Victoria Kogan, MD 5409 Avenue O, Fort Madison, IA 52627-9601 Ph: (319) 376-2134 |
News Archive
Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad' cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU's mutual recognition procedure.
The well-educated are significantly more open to the idea of "designing" babies than the poorly educated, according to a new study by psychologists at the University of East Anglia.
Scientists at the University of Liverpool argue that anti-obesity drugs fail to provide lasting benefits for health and wellbeing because they tackle the biological consequences of obesity, and not the important psychological causes of overconsumption and weight gain.
A team of researchers will use state-of-the-art brain imaging to unlock the secrets of a genetic disease, mucopolysaccharidosis, in a landmark study the team hope will lead to new treatments for this devastating disease.
In a letter released today by the White House today to Sen. Edward Kennedy, chairman of the Senate Committee on Health, Education, Labor and Pensions, and Sen. Max Baucus, chairman of the Senate Finance Committee, President Obama "suggests he may be open to a requirement that every American have health insurance, even though he opposed the so-called individual mandate in the presidential campaign," the Washington Post reports.
› Verified 3 days ago
Artemio Capili Santiago, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5409 Ave O, Suite 107, Fort Madison, IA 52627 Phone: 319-372-7270 Fax: 319-372-7279 | |
Dr. Pauline Mungai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Avenue O, Fort Madison, IA 52627 Phone: 319-376-2134 | |
Roseller Libarnes, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Avenue O, Fort Madison, IA 52627 Phone: 319-376-2134 Fax: 319-376-2188 | |
Lisa Bishop, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Avenue O, Fort Madison, IA 52627 Phone: 319-376-2134 Fax: 319-376-2188 |